NEW YORK (GenomeWeb News) — Vanderbilt University Medical Center is building a center that will study how proteomics and molecular markers can help develop diagnostics and drugs for cancer, the school said today.
Vanderbilt’s Center for Proteomics and Drug Actions is funded by a $1 million, five-year grant from the National Foundation for Cancer Research and will be linked with seven other university research centers in the US, UK, and in China, Vanderbilt said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

Sponsored by

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.